NATA - Nucleic Acid Therapy Accelerator
Alison Smith

AS

Alison Smith

Vice President, Portfolio And Technology Delivery, GSK at NATA - Nucleic Acid Therapy Accelerator

Org chart

View in org chart

Manager

Nick Lench

Executive Director

Peers

Shalini Andersson

Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)

Laura Sepp - Lorenzino

Chief Scientific Officer, Intellia Therapeutics (us)

Anne Willis

Professor Of Toxicology And MRC Toxicology Unit Director, University Of Cambridge (uk)

View in org chart

Timeline

Vice President, Portfolio And Technology Delivery, GSK
Current role